Blockchain Registration Transaction Record

GeoVax Urges U.S. Investment in Domestic Vaccine Production Amid Global Health Threats

GeoVax calls for urgent U.S. investment in domestic vaccine manufacturing to combat Mpox and COVID-19 variants, emphasizing the need for modern, American-made solutions.

The call for domestic vaccine manufacturing and diversification by GeoVax is critical in addressing the immediate and future public health threats posed by diseases like Mpox and COVID-19. With the global spread of Mpox and the continuous evolution of COVID-19 variants, the reliance on foreign vaccine supplies presents a significant risk to national biosecurity and public health. Investing in domestic solutions not only ensures a more resilient and responsive healthcare infrastructure but also supports the development of next-generation vaccines that can offer broader and longer-lasting immunity. This move is essential for protecting vulnerable populations and maintaining global health security.